The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Letters to the Editor

Letters to the Editor

July 1, 2007 • By Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF

In the old days, acute attacks were attenuated with ACTH and I have seen this work on several occasions. In your case, this might be like flogging a very tired horse. I doubt anyone could argue that a low, physiologic dose of systemic corticosteroid (prednisolone <8mg/d) produces immunosuppression and might be sufficient for the acute attack. If your patient had a brochospastic component, the pulmonary specialist would likely have recommended >2 mg/kg Q8hr with impunity. I would also give colchicine 0.6 mg BID for prophylaxis.

You Might Also Like
  • Letters to the Editor
  • Letters to the Editor
  • Letters to the Editor
Explore This Issue
July 2007
Also By This Author
  • Pain Perspective in Scleroderma

Matthew O. Swartz, MD, Rheumatologist

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Prince William Hospital, Manassas, Va.

 

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

I suggest either a moderated dose of systemic corticosteroids (i.e., prednisone 10 to 15 mg daily with a tapering regimen over two weeks) with continued close monitoring of fluid status or, if a clinician were feeling cavalier (vs. naive) enough or truly believed in his or her dexterity with a needle, an intra-articular corticosteroid injection to the affected gouty joint.

I recently had a similar situation and was able to maneuver a pleasant elderly woman out of it with the former tactic (though she had several affected gouty joints). Additionally, I have previously provided intra-articular corticosteroid injections to gouty joints in individuals who were anti-coagulated with thankful success. (Whether I possessed the correct thought process in attempting such a procedure under those conditions can be debated.) But I count my lucky stars that those individuals were able to avoid any complications from the procedure.

Lastly, I would also determine which option the treated individual prefers and/or is comfortable with and base my ultimate decision on their preference.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Dennis M. Liu, MD, Rheumatologist

Tuality Community Hospital, Hillsboro, Ore.

 

I have treated similar patients by injecting the joint with a 27-gauge, 1.5-inch needle. No problem with hemostasis.

Benjamin Lechner, MD, Rheumatologist

Hallandale, Fla.

 

Your patient was characteristic of 95% of those we now see, and meets “Lightfoot’s Criteria for Gout Needing a Rheumatologist”:

  1. Veteran;
  2. Heavy smoking history;
  3. Bruits in at least six sites, including at least one renal artery;
  4. Ejection fraction less than or equal to 25%;
  5. Creatinine around 2.5mg/dL on his or her best day;
  6. On coumadin for at least two of the following reasons:
    • Ventricular dilation with akinetic areas;
    • Recurrent thrombophlebitis;
    • Recurrent arterial thrombi from their plaques; and
    • An artificial heart valve.
  7. Enough exposure to alcohol to compromise easy regulation of prothrombin times; and
  8. Bronchopneumonia from tobacco-related lung disease.

In that setting, every drug for gout is contra-indicated. Therefore, the clinical decision-making is easy. You use the drug that is least worst.

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions, Crystal Arthritis Tagged With: Gout, Quality, TreatmentIssue: July 2007

You Might Also Like:
  • Letters to the Editor
  • Letters to the Editor
  • Letters to the Editor
  • Letters to the Editor

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.